메뉴 건너뛰기




Volumn 44, Issue 10, 2014, Pages 1228-1239

A comparative analysis of symptom and medication scoring methods used in clinical trials of sublingual immunotherapy for seasonal allergic rhinitis

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; BUDESONIDE; CETIRIZINE; CORTICOSTEROID; DESLORATADINE; FLUTICASONE PROPIONATE; LEVOCABASTINE; LORATADINE; MOMETASONE FUROATE; OLOPATADINE; PLACEBO; PREDNISONE; PSEUDOEPHEDRINE; STEROID;

EID: 84925816065     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12331     Document Type: Review
Times cited : (25)

References (48)
  • 1
    • 75849127328 scopus 로고    scopus 로고
    • Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009
    • Canonica GW, Bousquet J, Casale T et al. Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy 2009; 64(Suppl. 91):1-59.
    • (2009) Allergy , vol.64 , pp. 1-59
    • Canonica, G.W.1    Bousquet, J.2    Casale, T.3
  • 2
    • 84876903600 scopus 로고    scopus 로고
    • Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report
    • e3.
    • Burks AW, Calderon MA, Casale T et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol 2013; 131:1288-96.e3.
    • (2013) J Allergy Clin Immunol , vol.131 , pp. 1288-1296
    • Burks, A.W.1    Calderon, M.A.2    Casale, T.3
  • 3
    • 33846964159 scopus 로고    scopus 로고
    • Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce
    • Canonica GW, Baena-Cagnani CE, Bousquet J et al. Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007; 62:317-24.
    • (2007) Allergy , vol.62 , pp. 317-324
    • Canonica, G.W.1    Baena-Cagnani, C.E.2    Bousquet, J.3
  • 6
    • 79955444722 scopus 로고    scopus 로고
    • Allergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials?
    • Pfaar O, Kleine-Tebbe J, Hormann K, Klimek L. Allergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials? Immunol Allergy Clin North Am 2011; 31:289-309.
    • (2011) Immunol Allergy Clin North Am , vol.31 , pp. 289-309
    • Pfaar, O.1    Kleine-Tebbe, J.2    Hormann, K.3    Klimek, L.4
  • 7
    • 78650873829 scopus 로고    scopus 로고
    • Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults
    • e2.
    • Nelson HS, Nolte H, Creticos P, Maloney J, Wu J, Bernstein DI. Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults. J Allergy Clin Immunol 2011; 127:72-80.e2.
    • (2011) J Allergy Clin Immunol , vol.127 , pp. 72-80
    • Nelson, H.S.1    Nolte, H.2    Creticos, P.3    Maloney, J.4    Wu, J.5    Bernstein, D.I.6
  • 8
    • 84870294264 scopus 로고    scopus 로고
    • Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE
    • Cox LS, Casale TB, Nayak AS et al. Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE. J Allergy Clin Immunol 2012; 130:1327-34.
    • (2012) J Allergy Clin Immunol , vol.130 , pp. 1327-1334
    • Cox, L.S.1    Casale, T.B.2    Nayak, A.S.3
  • 9
    • 77955813106 scopus 로고    scopus 로고
    • Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents
    • Halken S, Agertoft L, Seidenberg J et al. Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents. Pediatr Allergy Immunol 2010; 21:970-6.
    • (2010) Pediatr Allergy Immunol , vol.21 , pp. 970-976
    • Halken, S.1    Agertoft, L.2    Seidenberg, J.3
  • 10
    • 58849093549 scopus 로고    scopus 로고
    • Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment
    • Horak F, Jaeger S, Worm M, Melac M, Didier A. Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment. Clin Exp Allergy 2009; 39:394-400.
    • (2009) Clin Exp Allergy , vol.39 , pp. 394-400
    • Horak, F.1    Jaeger, S.2    Worm, M.3    Melac, M.4    Didier, A.5
  • 11
    • 58149121462 scopus 로고    scopus 로고
    • Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy
    • Didier A, Melac M, Montagut A, Lheritier-Barrand M, Tabar A, Worm M. Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy. Allergy 2009; 64:166-71.
    • (2009) Allergy , vol.64 , pp. 166-171
    • Didier, A.1    Melac, M.2    Montagut, A.3    Lheritier-Barrand, M.4    Tabar, A.5    Worm, M.6
  • 12
    • 58149109018 scopus 로고    scopus 로고
    • Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis
    • e3.
    • Wahn U, Tabar A, Kuna P et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009; 123:160-6.e3.
    • (2009) J Allergy Clin Immunol , vol.123 , pp. 160-166
    • Wahn, U.1    Tabar, A.2    Kuna, P.3
  • 13
    • 84878353196 scopus 로고    scopus 로고
    • A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma
    • Murphy K, Gawchik S, Bernstein D, Andersen J, Rud Pedersen M. A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma. J Negat Results Biomed 2013; 12:10.
    • (2013) J Negat Results Biomed , vol.12 , pp. 10
    • Murphy, K.1    Gawchik, S.2    Bernstein, D.3    Andersen, J.4    Rud Pedersen, M.5
  • 14
    • 84880082661 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled, parallel trial of standardized short ragweed (RW) sublingual allergy immunotherapy liquid extract (RW-SAIL) in adult subjects with ragweed-induced allergic rhinoconjunctivitis
    • Creticos P, Esch R, Couroux P et al. A randomized, double-blind, placebo-controlled, parallel trial of standardized short ragweed (RW) sublingual allergy immunotherapy liquid extract (RW-SAIL) in adult subjects with ragweed-induced allergic rhinoconjunctivitis. J Allergy Clin Immunol 2013; 131(2 Suppl):AB146.
    • (2013) J Allergy Clin Immunol , vol.131 , Issue.2 Suppl , pp. AB146
    • Creticos, P.1    Esch, R.2    Couroux, P.3
  • 15
    • 67649210753 scopus 로고    scopus 로고
    • Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract
    • e1-5.
    • Amar SM, Harbeck RJ, Sills M, Silveira LJ, O'Brien H, Nelson HS. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract. J Allergy Clin Immunol 2009; 124:150-6.e1-5.
    • (2009) J Allergy Clin Immunol , vol.124 , pp. 150-156
    • Amar, S.M.1    Harbeck, R.J.2    Sills, M.3    Silveira, L.J.4    O'Brien, H.5    Nelson, H.S.6
  • 16
    • 58149118102 scopus 로고    scopus 로고
    • Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study
    • Ott H, Sieber J, Brehler R et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009; 64:1394-401.
    • (2009) Allergy , vol.64 , pp. 1394-1401
    • Ott, H.1    Sieber, J.2    Brehler, R.3
  • 17
    • 83755196755 scopus 로고    scopus 로고
    • Efficacy and safety of sublingual immunotherapy with grass monomeric allergoid: comparison between two different treatment regimens
    • Quercia O, Bruno ME, Compalati E, Falagiani P, Mistrello G, Stefanini GF. Efficacy and safety of sublingual immunotherapy with grass monomeric allergoid: comparison between two different treatment regimens. Eur Ann Allergy Clin Immunol 2011; 43:176-83.
    • (2011) Eur Ann Allergy Clin Immunol , vol.43 , pp. 176-183
    • Quercia, O.1    Bruno, M.E.2    Compalati, E.3    Falagiani, P.4    Mistrello, G.5    Stefanini, G.F.6
  • 19
    • 84869120896 scopus 로고    scopus 로고
    • High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study
    • e5.
    • Wahn U, Klimek L, Ploszczuk A et al. High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study. J Allergy Clin Immunol 2012; 130:886-93.e5.
    • (2012) J Allergy Clin Immunol , vol.130 , pp. 886-893
    • Wahn, U.1    Klimek, L.2    Ploszczuk, A.3
  • 20
    • 58149117614 scopus 로고    scopus 로고
    • Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy
    • e7.
    • Bufe A, Eberle P, Franke-Beckmann E et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009; 123:167-73.e7.
    • (2009) J Allergy Clin Immunol , vol.123 , pp. 167-173
    • Bufe, A.1    Eberle, P.2    Franke-Beckmann, E.3
  • 21
    • 73149111527 scopus 로고    scopus 로고
    • Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet
    • Durham SR, Emminger W, Kapp A et al. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010; 125:131-8.
    • (2010) J Allergy Clin Immunol , vol.125 , pp. 131-138
    • Durham, S.R.1    Emminger, W.2    Kapp, A.3
  • 22
    • 58849141205 scopus 로고    scopus 로고
    • Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen
    • Stelmach I, Kaczmarek-Wozniak J, Majak P, Olszowiec-Chlebna M, Jerzynska J. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen. Clin Exp Allergy 2009; 39:401-8.
    • (2009) Clin Exp Allergy , vol.39 , pp. 401-408
    • Stelmach, I.1    Kaczmarek-Wozniak, J.2    Majak, P.3    Olszowiec-Chlebna, M.4    Jerzynska, J.5
  • 23
    • 78650920807 scopus 로고    scopus 로고
    • Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents
    • e4.
    • Blaiss M, Maloney J, Nolte H, Gawchik S, Yao R, Skoner DP. Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents. J Allergy Clin Immunol 2011; 127:64-71.e4.
    • (2011) J Allergy Clin Immunol , vol.127 , pp. 64-71
    • Blaiss, M.1    Maloney, J.2    Nolte, H.3    Gawchik, S.4    Yao, R.5    Skoner, D.P.6
  • 24
    • 84878215291 scopus 로고    scopus 로고
    • Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults
    • e4.
    • Nolte H, Hebert J, Berman G et al. Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults. Ann Allergy Asthma Immunol 2013; 110:450-6.e4.
    • (2013) Ann Allergy Asthma Immunol , vol.110 , pp. 450-456
    • Nolte, H.1    Hebert, J.2    Berman, G.3
  • 25
    • 80052259321 scopus 로고    scopus 로고
    • Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis
    • Didier A, Worm M, Horak F et al. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 2011; 128:559-66.
    • (2011) J Allergy Clin Immunol , vol.128 , pp. 559-566
    • Didier, A.1    Worm, M.2    Horak, F.3
  • 28
    • 84876906083 scopus 로고    scopus 로고
    • Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults
    • e6.
    • Creticos PS, Maloney J, Bernstein DI et al. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults. J Allergy Clin Immunol 2013; 131:1342-9.e6.
    • (2013) J Allergy Clin Immunol , vol.131 , pp. 1342-1349
    • Creticos, P.S.1    Maloney, J.2    Bernstein, D.I.3
  • 29
    • 84857797855 scopus 로고    scopus 로고
    • SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial
    • e5.
    • Durham SR, Emminger W, Kapp A et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol 2012; 129:717-25.e5.
    • (2012) J Allergy Clin Immunol , vol.129 , pp. 717-725
    • Durham, S.R.1    Emminger, W.2    Kapp, A.3
  • 31
    • 79955375673 scopus 로고    scopus 로고
    • The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials
    • Grouin JM, Vicaut E, Jean-Alphonse S et al. The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials. Clin Exp Allergy 2011; 41:1282-8.
    • (2011) Clin Exp Allergy , vol.41 , pp. 1282-1288
    • Grouin, J.M.1    Vicaut, E.2    Jean-Alphonse, S.3
  • 32
    • 33947170595 scopus 로고    scopus 로고
    • Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines
    • Bousquet PJ, Combescure C, Neukirch F et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 2007; 62:367-72.
    • (2007) Allergy , vol.62 , pp. 367-372
    • Bousquet, P.J.1    Combescure, C.2    Neukirch, F.3
  • 33
    • 84881015437 scopus 로고    scopus 로고
    • Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis
    • Demoly P, Bousquet PJ, Mesbah K, Bousquet J, Devillier P. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy 2013; 43:881-8.
    • (2013) Clin Exp Allergy , vol.43 , pp. 881-888
    • Demoly, P.1    Bousquet, P.J.2    Mesbah, K.3    Bousquet, J.4    Devillier, P.5
  • 34
    • 77950853694 scopus 로고    scopus 로고
    • Olea sublingual allergoid immunotherapy administered with two different treatment regimens
    • Leonardi S, Arena A, Bruno ME et al. Olea sublingual allergoid immunotherapy administered with two different treatment regimens. Allergy Asthma Proc 2010; 31:e25-9.
    • (2010) Allergy Asthma Proc , vol.31 , pp. e25-e29
    • Leonardi, S.1    Arena, A.2    Bruno, M.E.3
  • 35
    • 84883053892 scopus 로고    scopus 로고
    • Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial
    • Aydogan M, Eifan AO, Keles S et al. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial. Respir Med 2013; 107:1322-9.
    • (2013) Respir Med , vol.107 , pp. 1322-1329
    • Aydogan, M.1    Eifan, A.O.2    Keles, S.3
  • 36
    • 84858795651 scopus 로고    scopus 로고
    • Sublingual immunotherapy not effective in house dust mite-allergic children in primary care
    • de Bot CM, Moed H, Berger MY et al. Sublingual immunotherapy not effective in house dust mite-allergic children in primary care. Pediatr Allergy Immunol 2012; 23:150-8.
    • (2012) Pediatr Allergy Immunol , vol.23 , pp. 150-158
    • de Bot, C.M.1    Moed, H.2    Berger, M.Y.3
  • 37
    • 79953659894 scopus 로고    scopus 로고
    • House dust mite sublingual immunotherapy: results of a US trial
    • e1-7.
    • Bush RK, Swenson C, Fahlberg B et al. House dust mite sublingual immunotherapy: results of a US trial. J Allergy Clin Immunol 2011; 127:974-81.e1-7.
    • (2011) J Allergy Clin Immunol , vol.127 , pp. 974-981
    • Bush, R.K.1    Swenson, C.2    Fahlberg, B.3
  • 38
    • 84861129636 scopus 로고    scopus 로고
    • Clinical efficacy of sublingual immunotherapy in pediatric patients with allergic rhinitis sensitized to house dust mites: comparison to adult patients
    • Han DH, Choi YS, Lee JE et al. Clinical efficacy of sublingual immunotherapy in pediatric patients with allergic rhinitis sensitized to house dust mites: comparison to adult patients. Acta Otolaryngol 2012; 132(Suppl. 1):S88-93.
    • (2012) Acta Otolaryngol , vol.132 , pp. S88-S93
    • Han, D.H.1    Choi, Y.S.2    Lee, J.E.3
  • 39
    • 77955607935 scopus 로고    scopus 로고
    • Clinical and immunologic effects of sublingual immunotherapy on patients with allergic rhinitis to house-dust mites: 1-year follow-up results
    • Kim ST, Han DH, Moon IJ, Lee CH, Min YG, Rhee CS. Clinical and immunologic effects of sublingual immunotherapy on patients with allergic rhinitis to house-dust mites: 1-year follow-up results. Am J Rhinol Allergy 2010; 24:271-5.
    • (2010) Am J Rhinol Allergy , vol.24 , pp. 271-275
    • Kim, S.T.1    Han, D.H.2    Moon, I.J.3    Lee, C.H.4    Min, Y.G.5    Rhee, C.S.6
  • 40
    • 79959764256 scopus 로고    scopus 로고
    • Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis
    • Lee JE, Choi YS, Kim MS et al. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis. Ann Allergy Asthma Immunol 2011; 107:79-84.
    • (2011) Ann Allergy Asthma Immunol , vol.107 , pp. 79-84
    • Lee, J.E.1    Choi, Y.S.2    Kim, M.S.3
  • 41
    • 84878143522 scopus 로고    scopus 로고
    • Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial
    • Wang DH, Chen L, Cheng L et al. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial. Laryngoscope 2013; 123:1334-40.
    • (2013) Laryngoscope , vol.123 , pp. 1334-1340
    • Wang, D.H.1    Chen, L.2    Cheng, L.3
  • 42
    • 78649981810 scopus 로고    scopus 로고
    • Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials
    • Durham SR, Birk AO, Andersen JS. Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials. Allergy 2011; 66:120-3.
    • (2011) Allergy , vol.66 , pp. 120-123
    • Durham, S.R.1    Birk, A.O.2    Andersen, J.S.3
  • 43
    • 0031838266 scopus 로고    scopus 로고
    • Immunotherapy as an effective tool in allergy treatment
    • Malling HJ. Immunotherapy as an effective tool in allergy treatment. Allergy 1998; 53:461-72.
    • (1998) Allergy , vol.53 , pp. 461-472
    • Malling, H.J.1
  • 44
    • 33744758057 scopus 로고    scopus 로고
    • Sublingual immunotherapy: efficacy-methodology and outcome of clinical trials
    • Malling HJ. Sublingual immunotherapy: efficacy-methodology and outcome of clinical trials. Allergy 2006; 61(Suppl. 81):24-8.
    • (2006) Allergy , vol.61 , pp. 24-28
    • Malling, H.J.1
  • 45
    • 76749093073 scopus 로고    scopus 로고
    • Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class
    • Benninger M, Farrar JR, Blaiss M et al. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class. Ann Allergy Asthma Immunol 2010; 104:13-29.
    • (2010) Ann Allergy Asthma Immunol , vol.104 , pp. 13-29
    • Benninger, M.1    Farrar, J.R.2    Blaiss, M.3
  • 46
    • 84855565794 scopus 로고    scopus 로고
    • Placebo effect in clinical trials involving patients with allergic rhinitis
    • del Cuvillo A, Sastre J, Bartra J et al. Placebo effect in clinical trials involving patients with allergic rhinitis. J Investig Allergol Clin Immunol 2011; 21(Suppl. 3):40-5.
    • (2011) J Investig Allergol Clin Immunol , vol.21 , pp. 40-45
    • del Cuvillo, A.1    Sastre, J.2    Bartra, J.3
  • 48
    • 84876702869 scopus 로고    scopus 로고
    • Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis
    • Didier A, Malling HJ, Worm M et al. Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis. Clin Exp Allergy 2013; 43:568-77.
    • (2013) Clin Exp Allergy , vol.43 , pp. 568-577
    • Didier, A.1    Malling, H.J.2    Worm, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.